Overview

Nasal Administration of Dexamethasone for Multiple Sclerosis (MS) Treatment

Status:
Withdrawn
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
The study aims to assess the safety and efficacy of nasale administration of Dexamethasone in relapsing MS patients
Phase:
Phase 1
Details
Lead Sponsor:
Hadassah Medical Organization
Treatments:
BB 1101
Dexamethasone
Dexamethasone 21-phosphate
Dexamethasone acetate